RxDoctor Payments Data

Nanette Cook, MD

Obstetrics & Gynecology · Smyrna, GANPI 1346215837

Payments from drug & device makers

$8,924in general payments, 2019–2025

Across 180 payments — averaging $49.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$4K
  • Sumitomo Pharma America, Inc.$2K
  • Novo Nordisk$438
  • Astellas Pharma US Inc$418
  • AbbVie$404
  • Mayne Pharma Commercial LLC$290
  • plus $1K from 28 others

What the payments were for

  • Consulting fees$3,33037%
  • Speaking & faculty fees$1,12013%
  • Travel & lodging$6437%
  • Food & beverage$3,65141%
  • Education$1802%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,924 in reported general payments places this provider in the 90th percentile of 1,324 obstetrics & gynecology providers in Georgia.

See all obstetrics & gynecology providers in Georgia

Medicare billing

Part B allowed, 2024
$5,940
Medicare patients
40
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide22$22,843
OzempicSemaglutide19$18,888
Estradiol (Twice Weekly)Estradiol11$1,759
Estradiol17$723
Metronidazole19$170
Metformin Hcl ErMetformin Hcl11$135
Fluconazole12$65

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$61$22,84322 claims
Novo NordiskOzempic$438$18,88819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,324 obstetrics & gynecology providers in Georgia.

Other obstetrics & gynecology in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →